| blastocyst growth | GO:0001832 | 23 | 1.000 | |
| inner cell mass cell proliferation | GO:0001833 | 15 | 1.000 | |
| transdifferentiation | GO:0060290 | 1 | 1.000 | |
| protein deacetylation | GO:0006476 | 32 | 1.000 | |
| mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis | GO:0072309 | 3 | 0.999 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.998 | |
| olfactory nerve development | GO:0021553 | 3 | 0.998 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.996 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.995 | |
| ureteric bud invasion | GO:0072092 | 3 | 0.995 | |
| negative regulation of posttranscriptional gene silencing | GO:0060149 | 1 | 0.993 | |
| thick ascending limb development | GO:0072023 | 2 | 0.992 | |
| metanephric ascending thin limb development | GO:0072218 | 2 | 0.992 | |
| neurohypophysis development | GO:0021985 | 2 | 0.989 | |
| histone deacetylation | GO:0016575 | 26 | 0.988 | |
| inner cell mass cell fate commitment | GO:0001827 | 2 | 0.981 | |
| blastocyst development | GO:0001824 | 80 | 0.979 | |
| chromatin modification | GO:0016568 | 187 | 0.975 | |
| metanephric thick ascending limb development | GO:0072233 | 2 | 0.973 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.970 | |
| gene silencing | GO:0016458 | 38 | 0.959 | |
| inner cell mass cell differentiation | GO:0001826 | 7 | 0.957 | |
| histone modification | GO:0016570 | 159 | 0.957 | |
| chromatin organization | GO:0006325 | 206 | 0.956 | |
| chromatin silencing | GO:0006342 | 15 | 0.941 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.935 | |
| stem cell development | GO:0048864 | 219 | 0.934 | |
| metanephric renal vesicle formation | GO:0072093 | 4 | 0.932 | |
| epithalamus development | GO:0021538 | 2 | 0.929 | |
| habenula development | GO:0021986 | 2 | 0.920 | |
| dna metabolic process | GO:0006259 | 303 | 0.907 | |
| regulation of heart induction by regulation of canonical wnt signaling pathway | GO:0090081 | 2 | 0.902 | |
| neural tube development | GO:0021915 | 160 | 0.894 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.893 | |
| proprioception | GO:0019230 | 4 | 0.893 | |
| neural tube patterning | GO:0021532 | 43 | 0.887 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.886 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.883 | |
| cellular response to lipid | GO:0071396 | 145 | 0.872 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.868 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.860 | |
| olfactory bulb interneuron development | GO:0021891 | 7 | 0.860 | |
| protein deacylation | GO:0035601 | 36 | 0.859 | |
| ureteric bud elongation | GO:0060677 | 6 | 0.858 | |
| blastocyst formation | GO:0001825 | 33 | 0.850 | |
| metanephric macula densa development | GO:0072227 | 1 | 0.834 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.831 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.826 | |
| eyelid development in camera type eye | GO:0061029 | 9 | 0.822 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.819 | |
| ventricular compact myocardium morphogenesis | GO:0003223 | 2 | 0.816 | |
| macula densa development | GO:0072024 | 1 | 0.810 | |
| ascending thin limb development | GO:0072021 | 2 | 0.782 | |
| trophectodermal cell differentiation | GO:0001829 | 21 | 0.774 | |
| diencephalon development | GO:0021536 | 63 | 0.735 | |
| negative regulation of mesoderm development | GO:2000381 | 8 | 0.730 | |
| negative regulation of gene silencing by rna | GO:0060967 | 1 | 0.712 | |
| proprioception involved in equilibrioception | GO:0051355 | 1 | 0.705 | |
| mrna transcription | GO:0009299 | 4 | 0.695 | |
| digestive tract development | GO:0048565 | 190 | 0.687 | |
| dna methylation | GO:0006306 | 43 | 0.670 | |
| regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0003339 | 5 | 0.637 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.637 | Human |
| methylation dependent chromatin silencing | GO:0006346 | 6 | 0.636 | |
| limb morphogenesis | GO:0035108 | 149 | 0.626 | |
| regionalization | GO:0003002 | 337 | 0.612 | |
| midbrain hindbrain boundary morphogenesis | GO:0021555 | 4 | 0.607 | |
| positive regulation of catenin import into nucleus | GO:0035413 | 2 | 0.602 | |
| regulation of hippo signaling | GO:0035330 | 1 | 0.597 | |
| dna alkylation | GO:0006305 | 43 | 0.588 | |
| ectodermal cell fate commitment | GO:0001712 | 1 | 0.584 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.573 | |
| renal vesicle development | GO:0072087 | 17 | 0.570 | |
| cranial nerve development | GO:0021545 | 41 | 0.565 | |
| metanephric distal convoluted tubule development | GO:0072221 | 5 | 0.557 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.552 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.549 | |
| stem cell differentiation | GO:0048863 | 268 | 0.549 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.547 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.542 | |
| stem cell fate specification | GO:0048866 | 3 | 0.540 | |
| developmental induction | GO:0031128 | 34 | 0.539 | |
| regulation of catenin import into nucleus | GO:0035412 | 5 | 0.538 | |
| loop of henle development | GO:0072070 | 10 | 0.530 | |
| negative regulation of metanephros development | GO:0072217 | 6 | 0.529 | |
| c21 steroid hormone biosynthetic process | GO:0006700 | 3 | 0.528 | |
| protein methylation | GO:0006479 | 81 | 0.514 | |
| olfactory bulb interneuron differentiation | GO:0021889 | 12 | 0.513 | |
| determination of left right asymmetry in nervous system | GO:0035545 | 1 | 0.501 | |
| face development | GO:0060324 | 38 | 0.499 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.495 | |
| visceral motor neuron differentiation | GO:0021524 | 3 | 0.491 | |
| renal system development | GO:0072001 | 225 | 0.486 | |
| cardiac muscle cell myoblast differentiation | GO:0060379 | 8 | 0.484 | |
| adenohypophysis development | GO:0021984 | 14 | 0.480 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.476 | |
| sensory system development | GO:0048880 | 3 | 0.462 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.458 | |
| tube formation | GO:0035148 | 140 | 0.455 | |
| gene silencing by rna | GO:0031047 | 19 | 0.447 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.447 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.429 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.420 | |
| dct cell differentiation | GO:0072069 | 3 | 0.419 | |
| regulation of transcription from rna polymerase ii promoter involved in heart development | GO:1901213 | 9 | 0.418 | |
| astrocyte development | GO:0014002 | 12 | 0.415 | |
| rostrocaudal neural tube patterning | GO:0021903 | 12 | 0.414 | |
| metanephric juxtaglomerular apparatus development | GO:0072206 | 1 | 0.406 | |
| negative regulation of gene silencing | GO:0060969 | 2 | 0.403 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.401 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.395 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.386 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.384 | |
| establishment of planar polarity involved in neural tube closure | GO:0090177 | 15 | 0.381 | |
| stem cell maintenance | GO:0019827 | 130 | 0.377 | |
| ectoderm formation | GO:0001705 | 3 | 0.375 | |
| positive regulation of branching involved in ureteric bud morphogenesis | GO:0090190 | 18 | 0.365 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.362 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.360 | |
| mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0003337 | 9 | 0.359 | |
| olfactory bulb development | GO:0021772 | 30 | 0.358 | |
| regulation of wnt signaling pathway involved in heart development | GO:0003307 | 5 | 0.350 | |
| olfactory lobe development | GO:0021988 | 32 | 0.350 | |
| specification of organ position | GO:0010159 | 3 | 0.350 | |
| ear morphogenesis | GO:0042471 | 118 | 0.347 | |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.343 | |
| negative regulation of androgen receptor signaling pathway | GO:0060766 | 3 | 0.337 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.336 | |
| limb development | GO:0060173 | 166 | 0.335 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.334 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.330 | |
| regulation of inositol phosphate biosynthetic process | GO:0010919 | 3 | 0.329 | |
| appendage development | GO:0048736 | 166 | 0.322 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.319 | |
| trophectodermal cellular morphogenesis | GO:0001831 | 3 | 0.317 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.312 | |
| regulation of methylation dependent chromatin silencing | GO:0090308 | 1 | 0.310 | |
| connective tissue development | GO:0061448 | 179 | 0.307 | |
| renal tubule development | GO:0061326 | 87 | 0.307 | |
| urogenital system development | GO:0001655 | 261 | 0.305 | |
| adaptive immune response | GO:0002250 | 155 | 0.300 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.299 | |
| skeletal system development | GO:0001501 | 356 | 0.289 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.287 | |
| immunoglobulin production | GO:0002377 | 73 | 0.287 | |
| mesoderm formation | GO:0001707 | 62 | 0.283 | |
| cochlea development | GO:0090102 | 35 | 0.282 | |
| neural tube closure | GO:0001843 | 90 | 0.282 | |
| angiogenesis | GO:0001525 | 201 | 0.281 | |
| epithelial cell development | GO:0002064 | 159 | 0.278 | |
| regulation of ectoderm development | GO:2000383 | 2 | 0.277 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.275 | |
| organ growth | GO:0035265 | 117 | 0.275 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.271 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.269 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.265 | |
| neural tube formation | GO:0001841 | 108 | 0.257 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.256 | |
| cardiac cell fate determination | GO:0060913 | 2 | 0.255 | |
| hypothalamus cell differentiation | GO:0021979 | 8 | 0.252 | |
| histone methylation | GO:0016571 | 71 | 0.246 | |
| pituitary gland development | GO:0021983 | 38 | 0.244 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.242 | |
| myoblast differentiation | GO:0045445 | 52 | 0.241 | |
| schwann cell development | GO:0014044 | 22 | 0.240 | |
| digestive system development | GO:0055123 | 200 | 0.240 | |
| hippo signaling | GO:0035329 | 11 | 0.239 | |
| endocrine system development | GO:0035270 | 98 | 0.235 | |
| tube closure | GO:0060606 | 91 | 0.231 | |
| mesenchymal to epithelial transition | GO:0060231 | 12 | 0.230 | |
| ventricular septum development | GO:0003281 | 42 | 0.227 | |
| positive regulation of transcription from rna polymerase ii promoter involved in heart development | GO:1901228 | 4 | 0.225 | |
| embryonic eye morphogenesis | GO:0048048 | 29 | 0.224 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.223 | |
| camera type eye development | GO:0043010 | 266 | 0.220 | |
| cochlea morphogenesis | GO:0090103 | 22 | 0.215 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.210 | |
| distal convoluted tubule development | GO:0072025 | 5 | 0.206 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.204 | |
| chromatin remodeling | GO:0006338 | 32 | 0.198 | |
| sensory perception of sound | GO:0007605 | 97 | 0.196 | |
| mesoderm development | GO:0007498 | 100 | 0.196 | |
| nephron epithelium development | GO:0072009 | 92 | 0.191 | |
| histone h2a ubiquitination | GO:0033522 | 3 | 0.190 | |
| epithelial cell maturation involved in prostate gland development | GO:0060743 | 4 | 0.190 | |
| habituation | GO:0046959 | 3 | 0.190 | |
| positive regulation of extracellular matrix organization | GO:1903055 | 4 | 0.189 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.189 | |
| biomineral tissue development | GO:0031214 | 64 | 0.187 | |
| negative regulation of kidney development | GO:0090185 | 15 | 0.186 | |
| somitogenesis | GO:0001756 | 69 | 0.186 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.186 | |
| negative regulation of exocytosis | GO:0045920 | 12 | 0.180 | |
| nephron development | GO:0072006 | 109 | 0.179 | |
| negative regulation of smoothened signaling pathway | GO:0045879 | 25 | 0.175 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.174 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.173 | |
| regulation of tongue muscle cell differentiation | GO:2001035 | 2 | 0.172 | |
| positive regulation of g0 to g1 transition | GO:0070318 | 2 | 0.171 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.170 | |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 | 3 | 0.169 | |
| neuromuscular process controlling posture | GO:0050884 | 14 | 0.168 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.168 | |
| female gonad development | GO:0008585 | 71 | 0.168 | |
| regulation of mesoderm development | GO:2000380 | 12 | 0.167 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.166 | |
| negative regulation of cardiac chamber formation | GO:1901211 | 1 | 0.165 | |
| mesenchyme development | GO:0060485 | 152 | 0.165 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.163 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.160 | |
| aldosterone metabolic process | GO:0032341 | 2 | 0.160 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.159 | |
| metanephros morphogenesis | GO:0003338 | 24 | 0.157 | |
| immunoglobulin secretion involved in immune response | GO:0002380 | 2 | 0.156 | |
| t cell activation | GO:0042110 | 289 | 0.156 | |
| organ induction | GO:0001759 | 21 | 0.155 | |
| negative regulation of cardiac chamber morphogenesis | GO:1901220 | 2 | 0.155 | |
| ear development | GO:0043583 | 200 | 0.155 | |
| metanephric nephron development | GO:0072210 | 34 | 0.155 | |
| developmental pigmentation | GO:0048066 | 40 | 0.154 | |
| kidney development | GO:0001822 | 213 | 0.152 | |
| respiratory tube development | GO:0030323 | 167 | 0.152 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.149 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.147 | |
| macromolecule methylation | GO:0043414 | 120 | 0.147 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.146 | |
| meiosis i | GO:0007127 | 60 | 0.146 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.145 | |
| locomotory behavior | GO:0007626 | 195 | 0.144 | |
| somite development | GO:0061053 | 81 | 0.143 | |
| lung development | GO:0030324 | 164 | 0.143 | |
| kidney epithelium development | GO:0072073 | 121 | 0.143 | |
| peptide secretion | GO:0002790 | 114 | 0.143 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.142 | |
| establishment of planar polarity of embryonic epithelium | GO:0042249 | 16 | 0.141 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.141 | |
| ectoderm development | GO:0007398 | 15 | 0.140 | |
| adrenal gland development | GO:0030325 | 18 | 0.140 | |
| regulation of cardiac chamber morphogenesis | GO:1901219 | 2 | 0.138 | |
| midbrain hindbrain boundary development | GO:0030917 | 9 | 0.138 | |
| gastrulation | GO:0007369 | 116 | 0.138 | |
| ectodermal placode formation | GO:0060788 | 16 | 0.138 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.135 | |
| metanephric renal vesicle morphogenesis | GO:0072283 | 12 | 0.134 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.134 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.133 | Human |
| respiratory system development | GO:0060541 | 190 | 0.133 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.132 | |
| renal vesicle morphogenesis | GO:0072077 | 15 | 0.132 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.132 | |
| histone acetylation | GO:0016573 | 41 | 0.129 | |
| rhythmic process | GO:0048511 | 174 | 0.129 | |
| rna interference | GO:0016246 | 2 | 0.127 | |
| regulation of transcription from rna polymerase i promoter | GO:0006356 | 6 | 0.126 | |
| gland development | GO:0048732 | 330 | 0.126 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.126 | |
| regulation of heart induction | GO:0090381 | 2 | 0.125 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.125 | |
| regulation of posttranscriptional gene silencing | GO:0060147 | 5 | 0.124 | |
| heart morphogenesis | GO:0003007 | 178 | 0.124 | |
| epithelial cell maturation | GO:0002070 | 15 | 0.124 | |
| mesodermal to mesenchymal transition involved in gastrulation | GO:0060809 | 1 | 0.123 | |
| dna modification | GO:0006304 | 50 | 0.122 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.121 | |
| fat pad development | GO:0060613 | 6 | 0.120 | |
| tongue muscle cell differentiation | GO:0035981 | 2 | 0.120 | |
| dendrite development | GO:0016358 | 115 | 0.119 | |
| equilibrioception | GO:0050957 | 3 | 0.119 | |
| endodermal cell fate commitment | GO:0001711 | 12 | 0.117 | Human |
| synapsis | GO:0007129 | 34 | 0.117 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.116 | |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.113 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.112 | |
| negative regulation of ectoderm development | GO:2000384 | 2 | 0.112 | |
| cell maturation | GO:0048469 | 127 | 0.112 | |
| bone development | GO:0060348 | 120 | 0.111 | |
| ovarian follicle development | GO:0001541 | 40 | 0.111 | |
| regulation of establishment of planar polarity involved in neural tube closure | GO:0090178 | 15 | 0.110 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.109 | |
| renal vesicle formation | GO:0072033 | 8 | 0.108 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.108 | |
| nose development | GO:0043584 | 12 | 0.107 | |
| protein secretion | GO:0009306 | 111 | 0.106 | |
| isotype switching | GO:0045190 | 36 | 0.106 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.106 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.106 | |
| regulation of mesonephros development | GO:0061217 | 24 | 0.106 | |
| dna dealkylation | GO:0035510 | 11 | 0.105 | |
| primary neural tube formation | GO:0014020 | 95 | 0.105 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.104 | |
| dna packaging | GO:0006323 | 30 | 0.103 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.103 | |
| cardiac septum development | GO:0003279 | 59 | 0.102 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.101 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.101 | |
| regulation of protein transport | GO:0051223 | 163 | 0.101 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.101 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.100 | |
| ureteric bud development | GO:0001657 | 94 | 0.100 | |
| positive regulation of immature t cell proliferation | GO:0033091 | 4 | 0.098 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.098 | |
| hypothalamus development | GO:0021854 | 16 | 0.097 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.097 | |
| olfactory placode development | GO:0071698 | 4 | 0.097 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.096 | |
| response to retinoic acid | GO:0032526 | 56 | 0.095 | |
| endoderm development | GO:0007492 | 45 | 0.095 | Human |
| smooth muscle tissue development | GO:0048745 | 22 | 0.095 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.094 | |
| regulation of dna methylation | GO:0044030 | 12 | 0.094 | |
| regulation of cardiac chamber formation | GO:1901210 | 1 | 0.092 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.091 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.091 | |
| lens epithelial cell proliferation | GO:0097166 | 1 | 0.090 | |
| nerve development | GO:0021675 | 67 | 0.090 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.090 | |
| chromosome organization involved in meiosis | GO:0070192 | 39 | 0.089 | |
| positive regulation of hippo signaling | GO:0035332 | 1 | 0.088 | |
| regulation of secretion | GO:0051046 | 274 | 0.088 | |
| embryonic camera type eye development | GO:0031076 | 36 | 0.088 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.087 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.087 | |
| sensory perception | GO:0007600 | 245 | 0.086 | |
| cardiac chamber development | GO:0003205 | 108 | 0.083 | |
| regulation of transcription involved in primary germ layer cell fate commitment | GO:0060796 | 2 | 0.082 | |
| mesodermal cell differentiation | GO:0048333 | 22 | 0.082 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.082 | |
| regulation of smad protein complex assembly | GO:0010990 | 1 | 0.081 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.081 | |
| chromatin mediated maintenance of transcription | GO:0048096 | 2 | 0.079 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.078 | |
| mineralocorticoid metabolic process | GO:0008212 | 2 | 0.078 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.078 | |
| tongue development | GO:0043586 | 18 | 0.078 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.078 | |
| positive regulation of inositol trisphosphate biosynthetic process | GO:0032962 | 2 | 0.078 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.078 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.078 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.077 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.076 | |
| response to acid chemical | GO:0001101 | 111 | 0.076 | |
| dna recombination | GO:0006310 | 92 | 0.076 | |
| b cell activation | GO:0042113 | 161 | 0.076 | |
| forebrain development | GO:0030900 | 302 | 0.076 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.076 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.075 | |
| nephron tubule development | GO:0072080 | 84 | 0.075 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.074 | |
| positive regulation of kidney development | GO:0090184 | 28 | 0.074 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.074 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.074 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.074 | |
| trophectodermal cell proliferation | GO:0001834 | 2 | 0.074 | |
| response to steroid hormone | GO:0048545 | 56 | 0.072 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.072 | |
| negative regulation of cell morphogenesis involved in differentiation | GO:0010771 | 48 | 0.072 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.072 | |
| inner cell mass cellular morphogenesis | GO:0001828 | 1 | 0.071 | |
| cell migration in hindbrain | GO:0021535 | 16 | 0.071 | |
| male sex determination | GO:0030238 | 14 | 0.071 | |
| prostate gland growth | GO:0060736 | 13 | 0.070 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.070 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.069 | |
| dorsal ventral neural tube patterning | GO:0021904 | 28 | 0.069 | |
| regulation of lens epithelial cell proliferation | GO:2001109 | 1 | 0.069 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.068 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.068 | |
| positive regulation of skeletal muscle tissue regeneration | GO:0043415 | 4 | 0.068 | |
| otic vesicle development | GO:0071599 | 14 | 0.068 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.068 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.068 | |
| multicellular organism growth | GO:0035264 | 161 | 0.067 | |
| heart induction | GO:0003129 | 2 | 0.067 | |
| trigeminal nerve development | GO:0021559 | 10 | 0.067 | |
| positive regulation of protein localization to nucleus | GO:1900182 | 30 | 0.067 | |
| metanephros development | GO:0001656 | 79 | 0.066 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.066 | |
| endoderm formation | GO:0001706 | 20 | 0.066 | Human |
| regulation of histone methylation | GO:0031060 | 30 | 0.065 | |
| lens morphogenesis in camera type eye | GO:0002089 | 24 | 0.065 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.065 | |
| placenta development | GO:0001890 | 140 | 0.065 | |
| bone morphogenesis | GO:0060349 | 78 | 0.065 | |
| gonad development | GO:0008406 | 141 | 0.064 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.063 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.063 | |
| ectodermal placode morphogenesis | GO:0071697 | 16 | 0.062 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.062 | |
| regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003256 | 6 | 0.062 | |
| germ line sex determination | GO:0018992 | 3 | 0.062 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.062 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.062 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.062 | |
| regulation of gene silencing by mirna | GO:0060964 | 4 | 0.062 | |
| regulation of ossification | GO:0030278 | 112 | 0.061 | |
| corticotropin hormone secreting cell differentiation | GO:0060128 | 3 | 0.061 | |
| telencephalon development | GO:0021537 | 186 | 0.061 | |
| definitive hemopoiesis | GO:0060216 | 20 | 0.061 | |
| metanephric nephron tubule development | GO:0072234 | 16 | 0.061 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.061 | |
| metanephric tubule development | GO:0072170 | 18 | 0.060 | |
| negative regulation of mesodermal cell fate specification | GO:0042662 | 3 | 0.060 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.060 | |
| neuron projection guidance | GO:0097485 | 141 | 0.060 | |
| male gonad development | GO:0008584 | 88 | 0.060 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.060 | |
| olfactory placode formation | GO:0030910 | 4 | 0.059 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.059 | |
| negative regulation of myoblast differentiation | GO:0045662 | 18 | 0.059 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.059 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.059 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.059 | |
| pulmonary valve formation | GO:0003193 | 1 | 0.058 | |
| positive regulation of lens epithelial cell proliferation | GO:2001111 | 1 | 0.058 | |
| planar cell polarity pathway involved in neural tube closure | GO:0090179 | 14 | 0.058 | |
| transcription from rna polymerase i promoter | GO:0006360 | 13 | 0.058 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.058 | |
| sinoatrial node cell differentiation | GO:0060921 | 3 | 0.057 | |
| male germ line sex determination | GO:0019100 | 2 | 0.057 | |
| positive regulation of skeletal muscle fiber differentiation | GO:1902811 | 2 | 0.057 | |
| retinal ganglion cell axon guidance | GO:0031290 | 18 | 0.057 | |
| palate development | GO:0060021 | 76 | 0.057 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.057 | |
| inositol trisphosphate biosynthetic process | GO:0032959 | 5 | 0.056 | |
| ureter urothelium development | GO:0072190 | 3 | 0.056 | |
| embryonic placenta development | GO:0001892 | 98 | 0.056 | |
| regulation of heart looping | GO:1901207 | 1 | 0.056 | |
| negative regulation of canonical wnt signaling pathway involved in neural plate anterior posterior pattern formation | GO:0060829 | 1 | 0.056 | |
| neuron fate specification | GO:0048665 | 30 | 0.056 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.055 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.055 | |
| regulation of gene silencing by rna | GO:0060966 | 5 | 0.055 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.055 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.054 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.054 | |
| regulation of extracellular matrix assembly | GO:1901201 | 2 | 0.054 | |
| juxtaglomerular apparatus development | GO:0072051 | 1 | 0.054 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.054 | |
| forebrain neuron fate commitment | GO:0021877 | 13 | 0.053 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.053 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.053 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.052 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.052 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.052 | |
| positive regulation of skeletal muscle cell differentiation | GO:2001016 | 4 | 0.052 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.052 | |
| immune effector process | GO:0002252 | 321 | 0.052 | |
| positive regulation of alcohol biosynthetic process | GO:1902932 | 5 | 0.052 | |
| stem cell division | GO:0017145 | 30 | 0.051 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.051 | |
| rna 3 end processing | GO:0031123 | 20 | 0.051 | |
| protein import into nucleus | GO:0006606 | 95 | 0.051 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.051 | |
| pallium development | GO:0021543 | 120 | 0.051 | |
| epidermis development | GO:0008544 | 187 | 0.051 | |
| skin development | GO:0043588 | 220 | 0.051 | |
| positive regulation of tongue muscle cell differentiation | GO:2001037 | 2 | 0.050 | |
| regulation of inositol trisphosphate biosynthetic process | GO:0032960 | 3 | 0.050 | |
| histone h4 deacetylation | GO:0070933 | 4 | 0.050 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.050 | |
| regulation of kidney development | GO:0090183 | 40 | 0.049 | |
| male sex differentiation | GO:0046661 | 109 | 0.049 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.049 | |
| preganglionic parasympathetic nervous system development | GO:0021783 | 17 | 0.049 | |
| mapk cascade | GO:0000165 | 281 | 0.049 | |
| regulation of mesenchymal cell apoptotic process | GO:2001053 | 14 | 0.049 | |
| cardiac atrium development | GO:0003230 | 24 | 0.049 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.049 | |
| immunoglobulin production involved in immunoglobulin mediated immune response | GO:0002381 | 43 | 0.048 | |
| transforming growth factor beta secretion | GO:0038044 | 1 | 0.048 | |
| neuron migration | GO:0001764 | 122 | 0.048 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.048 | |
| multi organism behavior | GO:0051705 | 62 | 0.047 | |
| mesenchymal stem cell maintenance involved in nephron morphogenesis | GO:0072038 | 7 | 0.047 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.047 | |
| circadian rhythm | GO:0007623 | 114 | 0.047 | |
| intrahepatic bile duct development | GO:0035622 | 2 | 0.046 | |
| female sex differentiation | GO:0046660 | 84 | 0.046 | |
| regulation of immunoglobulin production | GO:0002637 | 42 | 0.046 | |
| primary prostatic bud elongation | GO:0060516 | 2 | 0.046 | |
| positive regulation of mesonephros development | GO:0061213 | 20 | 0.045 | |
| neural crest cell migration | GO:0001755 | 32 | 0.045 | |
| renal vesicle induction | GO:0072034 | 3 | 0.045 | |
| face morphogenesis | GO:0060325 | 29 | 0.045 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.045 | |
| metanephric nephron morphogenesis | GO:0072273 | 19 | 0.045 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.044 | |
| muscle tissue development | GO:0060537 | 308 | 0.044 | |
| protein acylation | GO:0043543 | 64 | 0.044 | |
| mammary gland formation | GO:0060592 | 9 | 0.044 | |
| cellular response to estrogen stimulus | GO:0071391 | 12 | 0.044 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.043 | |
| regulation of organ formation | GO:0003156 | 34 | 0.043 | |
| axis elongation | GO:0003401 | 30 | 0.043 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.043 | |
